Brain Blogger

Can Drug Therapy Prevent Parkinson’s Disease?

A recent issue of the journal Neurology published two separate case-controlled studies that showed a decreased risk for Parkinson’s disease associated with both cholesterol-lowering medication and blood pressure-lowering medication.

A common class of cholesterol-lowering medications, HMG-CoA reductase inhibitors (also collectively called “statins”), includes the well-known and often-prescribed atorvastatin (Lipitor), simvastatin (Zocor), lovastatin (Altocor, Mevacor), and pravastatin (Pravachol). In the current study, each of these drugs, except pravastatin, was associated with a 60 to 70% decreased risk of Parkinson’s disease. … [visit site to read more]

---
Related Articles at Brain Blogger:

• Drugs and Pharmacology, Ninth Edition
• OCD Study a Boost for Non-Drug Advocates
• Parkinson’s Disease and Deep Brain Stimulation - Good Idea or Not?
• James Parkinson’s Disease
• A Step Closer to the Great “Gene” Sale?

If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.